SOURCE: Xtalks

Xtalks Webinars

August 18, 2017 07:30 ET

The Role of Clinical Endpoint Committees in Medical Device Trials, a New Webinar Presented by Premier Research and Hosted by Xtalks

TORONTO, ON--(Marketwired - August 18, 2017) - This webinar will discuss the value of clinical endpoint committees in medical device evaluation programs and explore the process of organizing, managing, and implementing a centralized adjudication process for standardizing study endpoints. The live broadcast takes place on Tuesday, September 12, 2017, with keynote speakers from Premier Research Joanne Emmett, Vice President of Medical Device & Diagnostics, and Janet Kube, Directorof Project Management.

Developers of medical devices face the challenge of defining efficacy and safety endpoints that are scientifically measurable, objective, and valid. Clinical trials are often driven by clinical events that may lack standard definitions or are subject to interpretation. In these scenarios, sponsors need a reliable method for reducing the impact of variability on conclusions drawn from analyses of outcomes data.

Independent endpoint assessment and adjudication committees, otherwise known as clinical endpoint committees (CEC), can play a significant role in reviewing and classifying suspected efficacy and/or safety endpoints to provide standardized endpoint outcomes for statistical analysis. This centralized adjudication process enhances the quality, validity, and integrity of study results, which can improve the likelihood of clinical trial success.

CEC-adjudicated endpoints may be used in critical decision-making processes including power estimations, periodic safety reviews by data monitoring committees or data safety and monitoring boards, sample size re-estimation and other interim analyses, and overall efficacy and safety analyses. Consequently, CEC-adjudicated outcomes need to be finalized and made available on an ongoing basis throughout the lifespan of a trial. By enabling more timely identification of efficacy signals or safety risks, central adjudication may facilitate go/no-go decisions and potentially reduce trial costs. Clinical endpoint committees, therefore, play an integral role in adaptive trial designs.

Sponsors who are considering use of a clinical endpoint committee should keep the following in mind to support successful central adjudication:

  • The study protocol should include a well-defined data capture strategy that addresses handling of suspected endpoint and adjudicated outcome data, which should be defined in a clinical endpoint committee charter
  • The study protocol should include a clearly delineated tactical plan for effective endpoint case management
  • The clinical endpoint committees' adjudication workflow must be structured to deliver consistent, reliable, and accurate results

Among the questions the speaker will address, are:

  • What methods should be considered to support accurate detection and reporting of all potential suspected endpoints?
  • How will the suspected endpoint and adjudicated outcome data be handled within the overall study data-capture plan?
  • What methods will be used to ensure that final adjudicated outcomes are complete and current?

For details or to register for this complimentary event visit: The Role of Clinical Endpoint Committees in Medical Device Trials

About Premier Research

Premier Research is a leading contract research organization serving the needs of biotechnology, pharmaceutical, and medical device companies worldwide. The company has a wealth of experience in the execution of global, regional, and local clinical development programs, with a special focus on addressing unmet needs in areas such as analgesia, CNS, rare diseases, medical device and diagnostics, oncology, and pediatric research. Premier Research operates in 84 countries and employs more than 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. With its mission to improve productivity in clinical development, the company aligns itself with the mission of its customers to bring new medical treatments to patients promptly, accurately, and cost-effectively.

To learn more about Premier Research visit: premier-research.com

About Xtalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2017/8/15/11G144218/Images/Premier_Research_logo-398906951265.jpg

Contact Information